questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Embolie et thrombose
Thrombose
Thrombose veineuse
Syndrome de Budd-Chiari
Syndrome de Budd-Chiari : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Syndrome de Budd-Chiari
Échographie
Imagerie par résonance magnétique
Tests sanguins
Fonction hépatique
Coagulation
Ascite
Douleur abdominale
Hypertrophie hépatique
Échographie Doppler
Flux sanguin
Obstruction veineuse
Biopsie hépatique
Lésions hépatiques
Diagnostic différentiel
Symptômes
5
Douleur abdominale
Syndrome de Budd-Chiari
Hépatomégalie
Ascite
Hypertension portale
Cavité abdominale
Jaunisse
Bilirubine
Syndrome de Budd-Chiari
Asymptomatique
Syndrome de Budd-Chiari
Forme chronique
Prévention
5
Prévention
Troubles de la coagulation
Obésité
Anticoagulants
Prévention
Thromboses
Habitudes de vie
Alimentation équilibrée
Exercice
Vaccination
Hépatite
Complications hépatiques
Surveillance
Maladies hépatiques
Troubles de la coagulation
Traitements
5
Anticoagulants
Transplantation hépatique
Procédures endovasculaires
Anticoagulants
Thrombose veineuse
Complications
Procédure endovasculaire
Angioplastie
Stenting
Transplantation hépatique
Insuffisance hépatique
Complications
Traitements symptomatiques
Diurétiques
Ascite
Complications
5
Complications
Insuffisance hépatique
Hypertension portale
Insuffisance hépatique
Syndrome de Budd-Chiari
Complications
Hypertension portale
Veine porte
Obstruction
Complications à long terme
Cirrhose
Syndrome de Budd-Chiari
Prévention
Traitement précoce
Surveillance
Facteurs de risque
5
Facteurs de risque
Troubles de la coagulation
Obésité
Obésité
Syndrome de Budd-Chiari
Facteurs de risque
Maladies hépatiques
Cirrhose
Syndrome de Budd-Chiari
Contraceptifs oraux
Thrombose
Facteurs de risque
Tabagisme
Problèmes vasculaires
Thrombose
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Budd-Chiari : Questions médicales les plus fréquentes",
"headline": "Syndrome de Budd-Chiari : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Budd-Chiari : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Budd-Chiari"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thrombose veineuse",
"url": "https://questionsmedicales.fr/mesh/D020246",
"about": {
"@type": "MedicalCondition",
"name": "Thrombose veineuse",
"code": {
"@type": "MedicalCode",
"code": "D020246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.830.925"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Budd-Chiari",
"alternateName": "Budd-Chiari Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D006502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None Shalimar",
"url": "https://questionsmedicales.fr/author/None%20Shalimar",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India."
}
},
{
"@type": "Person",
"name": "Akash Shukla",
"url": "https://questionsmedicales.fr/author/Akash%20Shukla",
"affiliation": {
"@type": "Organization",
"name": "Department of Gastroenterology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India."
}
},
{
"@type": "Person",
"name": "Joseph J Alukal",
"url": "https://questionsmedicales.fr/author/Joseph%20J%20Alukal",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Talan Zhang",
"url": "https://questionsmedicales.fr/author/Talan%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
},
{
"@type": "Person",
"name": "Paul J Thuluvath",
"url": "https://questionsmedicales.fr/author/Paul%20J%20Thuluvath",
"affiliation": {
"@type": "Organization",
"name": "Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Trends in Term Intrapartum Stillbirth in Norway.",
"datePublished": "2023-09-05",
"url": "https://questionsmedicales.fr/article/37755831",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2023.34830"
}
},
{
"@type": "ScholarlyArticle",
"name": "Continuity of care in general practice in Norway.",
"datePublished": "2024-07-11",
"url": "https://questionsmedicales.fr/article/38991043",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0305164"
}
},
{
"@type": "ScholarlyArticle",
"name": "IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results.",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38779911",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/1651-226X.2024.28322"
}
},
{
"@type": "ScholarlyArticle",
"name": "Implementation of Advance Care Planning in Norway.",
"datePublished": "2023-07-01",
"url": "https://questionsmedicales.fr/article/37394337",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.zefq.2023.05.017"
}
},
{
"@type": "ScholarlyArticle",
"name": "Types of exams used in medical education in Norway.",
"datePublished": "2022-08-12",
"url": "https://questionsmedicales.fr/article/35997188",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4045/tidsskr.22.0337"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thrombose",
"item": "https://questionsmedicales.fr/mesh/D013927"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thrombose veineuse",
"item": "https://questionsmedicales.fr/mesh/D020246"
},
{
"@type": "ListItem",
"position": 7,
"name": "Syndrome de Budd-Chiari",
"item": "https://questionsmedicales.fr/mesh/D006502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Budd-Chiari - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Budd-Chiari",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Budd-Chiari",
"description": "Comment diagnostiquer le syndrome de Budd-Chiari ?\nQuels tests sanguins sont utiles ?\nQuels signes cliniques indiquent ce syndrome ?\nL'échographie Doppler est-elle utile ?\nQuand envisager une biopsie hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Budd-Chiari",
"description": "Quels sont les symptômes courants ?\nLa douleur abdominale est-elle fréquente ?\nQu'est-ce que l'ascite ?\nLa jaunisse est-elle un symptôme ?\nPeut-on avoir des symptômes asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Budd-Chiari",
"description": "Comment prévenir le syndrome de Budd-Chiari ?\nLes anticoagulants peuvent-ils prévenir ce syndrome ?\nQuelles habitudes de vie adopter ?\nLes vaccinations sont-elles importantes ?\nFaut-il surveiller les maladies hépatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Budd-Chiari",
"description": "Quels traitements sont disponibles ?\nQuand utiliser des anticoagulants ?\nQu'est-ce qu'une procédure endovasculaire ?\nQuand envisager une transplantation hépatique ?\nY a-t-il des traitements symptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Budd-Chiari",
"description": "Quelles sont les complications possibles ?\nL'insuffisance hépatique est-elle fréquente ?\nQu'est-ce que l'hypertension portale ?\nPeut-on avoir des complications à long terme ?\nLes complications peuvent-elles être évitées ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Budd-Chiari",
"description": "Quels sont les principaux facteurs de risque ?\nL'obésité augmente-t-elle le risque ?\nLes maladies hépatiques sont-elles un risque ?\nLes contraceptifs oraux sont-ils un facteur ?\nLe tabagisme influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006502?mesh_terms=Norway#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer le syndrome de Budd-Chiari ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'échographie, l'IRM et des tests sanguins pour évaluer la fonction hépatique."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les marqueurs de la fonction hépatique et les tests de coagulation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent ce syndrome ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'ascite, la douleur abdominale et l'hypertrophie du foie."
}
},
{
"@type": "Question",
"name": "L'échographie Doppler est-elle utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'évaluer le flux sanguin dans les veines hépatiques et de détecter des obstructions."
}
},
{
"@type": "Question",
"name": "Quand envisager une biopsie hépatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie peut être envisagée si le diagnostic est incertain ou pour évaluer des lésions hépatiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleur abdominale, jaunisse et ascite."
}
},
{
"@type": "Question",
"name": "La douleur abdominale est-elle fréquente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur abdominale est un symptôme fréquent, souvent localisée dans la partie supérieure droite."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'ascite ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ascite est l'accumulation de liquide dans la cavité abdominale, souvent causée par une hypertension portale."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse, due à une accumulation de bilirubine, est un symptôme courant du syndrome."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent être asymptomatiques, surtout dans les formes chroniques."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome de Budd-Chiari ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut la gestion des facteurs de risque comme les troubles de la coagulation et l'obésité."
}
},
{
"@type": "Question",
"name": "Les anticoagulants peuvent-ils prévenir ce syndrome ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anticoagulants peuvent prévenir les thromboses chez les patients à risque."
}
},
{
"@type": "Question",
"name": "Quelles habitudes de vie adopter ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter une alimentation équilibrée, faire de l'exercice et éviter le tabac sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se faire vacciner contre l'hépatite peut réduire le risque de complications hépatiques."
}
},
{
"@type": "Question",
"name": "Faut-il surveiller les maladies hépatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, surveiller les maladies hépatiques et les troubles de la coagulation est crucial pour la prévention."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des anticoagulants, des procédures endovasculaires et, dans certains cas, une transplantation hépatique."
}
},
{
"@type": "Question",
"name": "Quand utiliser des anticoagulants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants sont utilisés pour traiter les thromboses veineuses hépatiques et prévenir les complications."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une procédure endovasculaire ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une intervention pour débloquer les veines hépatiques, souvent par angioplastie ou stenting."
}
},
{
"@type": "Question",
"name": "Quand envisager une transplantation hépatique ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée en cas d'insuffisance hépatique sévère ou de complications irréversibles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements symptomatiques ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements symptomatiques comme les diurétiques peuvent aider à gérer l'ascite."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, la thrombose et l'hypertension portale."
}
},
{
"@type": "Question",
"name": "L'insuffisance hépatique est-elle fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'insuffisance hépatique est une complication grave pouvant survenir dans ce syndrome."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hypertension portale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension portale est une augmentation de la pression dans la veine porte, causée par l'obstruction."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications à long terme comme la cirrhose peuvent se développer si non traitées."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par un traitement précoce et une surveillance régulière."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent les troubles de la coagulation, l'obésité, et certaines maladies hépatiques."
}
},
{
"@type": "Question",
"name": "L'obésité augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est un facteur de risque connu pour le syndrome de Budd-Chiari."
}
},
{
"@type": "Question",
"name": "Les maladies hépatiques sont-elles un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies hépatiques, comme la cirrhose, augmentent le risque de ce syndrome."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation prolongée de contraceptifs oraux peut augmenter le risque de thrombose."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut contribuer à des problèmes vasculaires, augmentant le risque de thrombose."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
4 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore, MD, USA.
Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
3 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
College of Medicine and Biological Information Engineering, Northeastern University, Shenyang, China.
Liver Cirrhosis Study Group, Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China.
Department of Life Sciences and Biopharmaceutis, Shenyang Pharmaceutical University, Shenyang, China.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Seth Gordhandas Sunderdas Medical College and King Edward Memorial Hospital, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition Unit, All India Institute of Medical Sciences, New Delhi, 110 029, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi 110029, Delhi, India.
Publications dans "Syndrome de Budd-Chiari" :
2 publications dans cette catégorie
Affiliations :
Department of Gastroenterology, Seth G S Medical College and KEM Hospital, Parel, Mumbai, 400012, India.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
1 publication dans cette catégorie
Affiliations :
Department of Interventional Radiology, The Affiliated Hospital of XuZhou Medical University, Province Jiangsu, PR China.
Publications dans "Syndrome de Budd-Chiari" :
Fetal death during labor at term is a complication that is rarely studied in high-income countries. There is a need for large population-based studies to examine the rate of term intrapartum stillbirt...
To evaluate trends in term intrapartum stillbirth over time and to investigate the association between the trends and term intrapartum stillbirth risk factors from 1999 to 2018 in Norway....
This cohort study used data from the Medical Birth Registry of Norway from 1999 to 2018 to examine rates of term intrapartum stillbirth and risk factors associated with this event. A population of 1 0...
The main exposure variable was time, which was divided into four 5-year periods: 1999 to 2003, 2004 to 2008, 2009 to 2013, and 2014 to 2018....
The primary study outcome was term intrapartum stillbirth. Risk ratios were calculated, and multivariable logistic regression analyses were conducted to identify factors associated with secular trends...
The study population consisted of 1 021 268 term singleton births (maternal mean [SD] age, 29.72 [5.01] years; mean [SD] gestational age, 39.69 [1.27] weeks). During the study period, there were 95 te...
Findings of this study suggest that, despite increases in maternal and obstetric risk factors, term intrapartum stillbirth rates substantially decreased during the study period. Reasons for this decre...
Maintaining continuity of care between doctors and patients is considered a fundamental aspect of quality in primary healthcare. In this study, we aim to examine continuity in Norway over time by comp...
We employ individual-level data, which covers all primary care consultations. This data includes the identities of each patient and physician, and we can identify each patient's regular general practi...
Our findings reveal that, at the national level, SLICC and UPC exhibit remarkable stability, reaching 64 and 71 percent, respectively, in 2021. However, there is significant geographical variation, wi...
Our results demonstrate a high degree of continuity that has been stable over time. However, large geographical variations suggest that policymakers should strive to reduce geographical disparities in...
In Norway, comprehensive molecular tumour profiling is implemented as part of the public healthcare system. A substantial number of tumours harbour potentially targetable molecular alterations. Therap...
IMPRESS-Norway is a national, prospective, non-randomised, precision cancer medicine trial, offering treatment to patients with advanced-stage disease, progressing on standard treatment. Comprehensive...
Between April 2021 and October 2023, 1,167 patients were screened, and an actionable mutation with matching drug was identified for 358 patients. By the data cut off 186 patients have initiated treatm...
Precision cancer medicine demonstrates encouraging clinical effect in a subset of patients included in the IMPRESS-Norway trial....
Advance Care Planning has a relatively short history in the Norwegian health care services. This article gives an overview of advance care planning research and its implementation in the health care s...
No overview exists of the types of exams used in medical education in Norway. In this study, we have identified these and analysed the reasons why directors of studies choose a particular type of exam...
We gathered information about the types of exams used in the four undergraduate medical education programmes in Norway. We also conducted semi-structured interviews with a director of studies at each ...
The number of exams, the types of exams and their position in the study programme varied considerably across the four study programmes. Multiple-choice exams were the most common, supplemented with va...
Assessment seems to be largely intended to measure and control, while the opportunities to foster learning that examination affords are not well exploited. Systems thinking in relation to the differen...
When the COVID-19 virus hit the world, immigrants were overrepresented among those infected. In Norway, throughout the pandemic, there were far higher infection rates in people of Somali and Pakistani...
To explore and compare physicians' reported moral distress in 2004 and 2021 and identify factors that could be related to these responses....
Longitudinal survey....
Data were gathered from the Norwegian Physician Panel Study, a representative sample of Norwegian physicians, conducted in 2004 and 2021....
1499 physicians in 2004 and 2316 physicians in 2021....
The same survey instrument was used to measure change in moral distress from 2004 to 2021. Logistic regression analyses examined the role of gender, age and place of work....
Response rates were 67% (1004/1499) in 2004 and 71% (1639/2316) in 2021. That patient care is deprived due to time constraints is the most severe dimension of moral distress among physicians, and it h...
In 2004 and 2021 physicians' moral distress related to scarcity of time or unfair distribution of resources was high. Moral distress associated with resource scarcity and acting against one's conscien...
As a component of the thyroid hormones (THs), iodine is vital for normal neurodevelopment during early life. However, both deficient and excess iodine may affect TH production, and data on iodine stat...
To describe iodine nutrition (iodine status and intake) in children ≤2 y of age in Innlandet County (Norway) and to describe the associations with maternal iodine nutrition....
A cross-sectional study was performed in a representative sample of mother-child pairs selected from 30 municipalities from November 2020 until October 2021. Iodine status [child urinary iodine concen...
The median UIC in 333 children was 145 μg/L, indicating adequate iodine status according to the WHO cutoff (100 μg/L). The median usual iodine intake was 83 μg/d. Furthermore, 35% had suboptimal usual...
Despite a median UIC above the cutoff for iodine sufficiency, more than a third of the children had suboptimal usual iodine intakes. Our findings suggest that many children will benefit from iodine fo...
Monitoring melanoma incidence time trends by tumour thickness is essential to understanding the evolution of melanoma occurrence and guiding prevention strategies. To assess long-term incidence trends...
Rhizosphere microbial communities can influence plant growth and development. Natural regeneration processes take place in the tree stands of protected areas, which makes it possible to observe the na...